Skip to main content

Find Clinical Trials

Home
Conditions
Pulmonary Disease, Chronic Obstructive

Clinical trial condition

Pulmonary Disease, Chronic Obstructive

Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.

787 public trials 11 recruiting studies

Refine in advanced search Browse all conditions

Pulmonary Disease, Chronic Obstructive trial results

Completed

Study of Inhaler Device Attributes Investigating Critical and Overall Errors, Ease of Use, and Preference Between a Number of Inhaler Devices

NCT02184624

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: GSK Investigational Site Almere Stad, Netherlands

GSK Investigational Site Beek, Netherlands

GSK Investigational Site Enschede, Netherlands

GSK Investigational Site Kloosterhaar, Netherlands

View Trial Details

Completed

Risk of Re-Hospitalization in Patients With Chronic Obstructive Pulmonary Disease (COPD) Post Exacerbation

NCT01381458

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Outcomes From Initial Maintenance Therapy With Fluticasone Propionate 250/Salmeterol 50 (FSC) or Tiotropium in Chronic Obstructive Pulmonary Disease

NCT01387178

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Outcomes Associated With Early or Delayed Maintenance Treatment Post-Chronic Obstructive Pulmonary Disease Exacerbation

NCT01431911

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Outcomes for Chronic Obstructive Pulmonary Disease Moderate Exacerbators Initiating Treatment

NCT01395875

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Korean Chronic Obstructive Pulmonary Disease(COPD) Assessment Test Validation Study

NCT01424527

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: GSK Investigational Site Anyang-si, South Korea

GSK Investigational Site Busan, South Korea

GSK Investigational Site Gyung Gi Do, South Korea

GSK Investigational Site Incheon, South Korea

View Trial Details

Completed

Neutrophil Imaging in Healthy Subjects Following Lipopolysaccharide or Saline Challenge and in Subjects With Chronic Obstructive Pulmonary Disease

NCT02551614

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: GSK Investigational Site Cambridge, United Kingdom

GSK Investigational Site Cambridge, United Kingdom

View Trial Details

Completed

Pharmacokinetic Study in Healthy Volunteers to Characterise the Exposure of Fluticasone Furoate (FF), Vilanterol (VI) and Umeclidinium (UMEC) at Two Different Doses

NCT01894386

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: GSK Investigational Site Baltimore, Maryland, United States

View Trial Details

Completed

Method Validation Study to Explore the Sensitivity of SenseWear Armband Gecko for Measuring Physical Activity in Subjects With Chronic Obstructive Pulmonary Disease (COPD) & Asthma

NCT02619357

Conditions: Asthma, Behavior, Bronchial Diseases, +13 more
Locations: GSK Investigational Site Cambridge, United Kingdom

View Trial Details

Completed

GSK961081 Alone and With Fluticasone Furoate (FF), Phase 1 (Ph1), Single Dose Regimen (SD), Repeat Dose Regimen (RD), Pharmacokinetic (PK) Study in Healthy Volunteer (HV)

NCT02666287

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: GSK Investigational Site London, United Kingdom

View Trial Details